Postnatal Steroids in Preterm Infants: A Narrative Review Series—Part 3: Impacts on Growth, Neurodevelopment & Nutrition
5
item.page.dc.date.issued
2026-04-01
item.page.dc.type
item.page.dc.identifier.eissn
22279067
item.page.dc.identifier.doi
item.page.dc.identifier.scopus
2-s2.0-105037221928
item.page.oaire.citation.title
Children
item.page.oaire.citation.volume
13
item.page.oaire.citation.issue
4
item.page.dc.rights.holder
SCOPUS
item.page.dc.identifier.citation
Children Vol.13 No.4 (2026)
punsarn.item.page.citation
Plessas-Azurduy P., Garfinkle J., Beltempo M., Porraccio C., Lapointe A., Wazneh L., Wutthigate P., Spénard S., Sbrocchi A.M., Racine M.B., Mawad W., Cavallé-Garrido T., Shalish W., Sant’Anna G., Altit G. Postnatal Steroids in Preterm Infants: A Narrative Review Series—Part 3: Impacts on Growth, Neurodevelopment & Nutrition. Children Vol.13 No.4 (2026). doi:10.3390/children13040475 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/116547
item.page.dc.title
Postnatal Steroids in Preterm Infants: A Narrative Review Series—Part 3: Impacts on Growth, Neurodevelopment & Nutrition
item.page.dc.contributor.author
item.page.oairecerif.author.affiliation
item.page.dc.contributor.correspondence
item.page.dc.contributor.other
item.page.dc.description.abstract
Background: Postnatal corticosteroids (CS) improve respiratory outcomes in preterm infants, but effects on growth and neurodevelopment remain incompletely understood. Methods: This third instalment of a narrative review series builds on physiologic principles to examine systemic CS consequences. Main Findings: We explore the interplay between growth restriction, hypoxia, and neurodevelopmental vulnerability, discussing brain imaging, metabolic disruptions, and HPA axis suppression. Conclusion: This review advocates for a holistic, physiology-informed approach to optimize outcomes by integrating nutritional vulnerability with cardiorespiratory status.